(Q41585661)

4 October 2017

1 reference

title

Cytokine-induced autoimmune disorders (English)

1 reference

4 October 2017

P Miossec

1

1 reference

4 October 2017

1 August 1997

1 reference

4 October 2017

1 reference

4 October 2017

17

1 reference

4 October 2017

93-104

1 reference

4 October 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199717020-00002

4 October 2017

0 references

cites work

Thyroid disorders in 2 cases of acute myeloid leukaemia following treatment with recombinant interleukin-2 infusion

1 reference

12 December 2020

An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2

1 reference

12 December 2020

Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C

1 reference

12 December 2020

Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature

1 reference

12 December 2020

Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B

1 reference

12 December 2020

Thyroid dysfunction associated with immunotherapy for patients with cancer

1 reference

12 December 2020

Thrombocytopenic purpura and hepatitis C virus infection.

1 reference

12 December 2020

Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy.

1 reference

12 December 2020

Human TH1 and TH2 subsets: doubt no more

1 reference

12 December 2020

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia

1 reference

12 December 2020

Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B

1 reference

12 December 2020

CD4+ T cell-mediated leukopenia of Felty's syndrome successfully treated with granulocyte-colony-stimulating factor and methotrexate

1 reference

12 December 2020

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.

1 reference

12 December 2020

Sarcoidosis following beta-interferon therapy for multiple myeloma

1 reference

12 December 2020

Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration

1 reference

12 December 2020

Acute arthritis following interferon-alpha therapy

1 reference

12 December 2020

Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome

1 reference

12 December 2020

Treatment with alpha interferon associated with the development of paraneoplastic pemphigus

1 reference

12 December 2020

Myasthenia gravis induced by alpha-interferon therapy

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Autoimmune thyroid dysfunctions in hematologic malignancies treated with alpha-interferon

1 reference

12 December 2020

Interferon or hepatitis C virus induced autoimmune aplastic anemia and severe thrombocytopenia? A case report

1 reference

12 December 2020

Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection

1 reference

12 December 2020

G-CSF improves granulocytopenia in Felty's syndrome without flare-up of arthritis

1 reference

12 December 2020

alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.

1 reference

12 December 2020

Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.

1 reference

12 December 2020

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

1 reference

12 December 2020

Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma

1 reference

12 December 2020

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

1 reference

12 December 2020

Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma.

1 reference

12 December 2020

Bypassing the antigen to control rheumatoid arthritis

1 reference

12 December 2020

Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy

1 reference

12 December 2020

Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma

1 reference

12 December 2020

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

12 December 2020

Does interferon precipitate rejection of liver allografts?

1 reference

12 December 2020

Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia

1 reference

12 December 2020

Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash

1 reference

12 December 2020

Guillain Barré syndrome, a possible side effect of buffy coat transfusion and IFN alpha therapy in relapsed CML after bone marrow transplantation

1 reference

12 December 2020

Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I study

1 reference

12 December 2020

Autoimmunity as a complication of interleukin 2 immunotherapy. Many unanswered questions

1 reference

12 December 2020

Induction of insulin antibodies and insulin allergy under alpha-interferon treatment of renal cell carcinoma in a patient with insulin-treated diabetes mellitus--a case report

1 reference

12 December 2020

Hepatitis C virus, autoimmune liver disease and cryoglobulinaemic hepatitis

1 reference

12 December 2020

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function

1 reference

12 December 2020

Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment

1 reference

12 December 2020

Interferon-beta downregulates interferon-gamma-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells

1 reference

12 December 2020

Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia

1 reference

12 December 2020

Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia

1 reference

12 December 2020

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

1 reference

12 December 2020

Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial

1 reference

12 December 2020

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy.

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura during interferon-alpha 2B treatment for chronic hepatitis

1 reference

12 December 2020

Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon

1 reference

12 December 2020

Incomplete Reiter's syndrome induced by systemic interferon alpha treatment

1 reference

12 December 2020

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

1 reference

12 December 2020

Antierythrocyte autoantibody formation after therapy with interleukin-2 and gamma-interferon

1 reference

12 December 2020

Interleukin-2: a possible trigger for autoimmunity

1 reference

12 December 2020

Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease

1 reference

12 December 2020

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

1 reference

12 December 2020

Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a

1 reference

12 December 2020

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders

1 reference

12 December 2020

Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis

1 reference

12 December 2020

Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation

1 reference

12 December 2020

Activation of the complement system during immunotherapy of cancer with interleukin-2: a possible explanation of the capillary leak syndrome

1 reference

12 December 2020

Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients

1 reference

12 December 2020

Myasthenia gravis during interferon alfa therapy

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Carpal tunnel syndrome associated with interleukin-2 therapy

1 reference

12 December 2020

Dramatic worsening of hepatitis C virus-related cryoglobulinemia subsequent to treatment with interferon alfa

1 reference

12 December 2020

Autoimmune hepatitis and viral infection.

1 reference

12 December 2020

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

12 December 2020

Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

1 reference

12 December 2020

Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection

1 reference

12 December 2020

Interleukin-2, a pro-autoimmune lymphokine that interferes with post-deletional tolerance.

1 reference

12 December 2020

Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF)

1 reference

12 December 2020

Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy

1 reference

12 December 2020

Adverse reaction to contrast material in a patient treated with local interleukin-2

1 reference

12 December 2020

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

12 December 2020

Granulocyte colony-stimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient

1 reference

12 December 2020

Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia

1 reference

12 December 2020

Suppressed thyroid-stimulating hormone secretion in patients treated with interleukin-2 and interferon-alpha 2b for metastatic melanoma

1 reference

12 December 2020

Hypersensitivity reactions to chemotherapy agents in patients receiving chemoimmunotherapy with high-dose interleukin 2

1 reference

12 December 2020

Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool

1 reference

12 December 2020

Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis

1 reference

12 December 2020

Occurrence of IDDM during interferon therapy for chronic viral hepatitis

1 reference

12 December 2020

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

1 reference

12 December 2020

Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons

1 reference

12 December 2020

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

12 December 2020

Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

1 reference

12 December 2020

Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis

1 reference

12 December 2020

Systemic lupus erythematosus in a child receiving long-term interferon therapy

1 reference

12 December 2020

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study

1 reference

12 December 2020

Interferon-alpha-induced acute renal allograft rejection

1 reference

12 December 2020

Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies

1 reference

12 December 2020

Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients

1 reference

12 December 2020

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

1 reference

12 December 2020

Myositis following treatment with high dose interleukin-2 for malignancy

1 reference

12 December 2020

Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes

1 reference

12 December 2020

Interferon gamma inhibits interleukin 10 production by monocytes

1 reference

12 December 2020

The skin: an immunoreactive target organ during interleukin-2 administration?

1 reference

12 December 2020

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

1 reference

12 December 2020

Prospective 5-year followup of recombinant interferon-gamma in rheumatoid arthritis

1 reference

12 December 2020

Effects of Interferon-γ Therapy on Thyroid Function, T-Lymphocyte Subpopulations and Induction of Autoantibodies

1 reference

12 December 2020

Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis

1 reference

12 December 2020

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

1 reference

12 December 2020

The first case of polymyositis associated with interferon therapy

1 reference

12 December 2020

Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy

1 reference

12 December 2020

Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.

1 reference

12 December 2020

Alpha interferon in the treatment of mixed cryoglobulinaemia patients

1 reference

12 December 2020

Systemic lupus erythematosus following interferon therapy

1 reference

12 December 2020

Adult-onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitis

1 reference

12 December 2020

Arthritis in patients with psoriasis treated with gamma-interferon

1 reference

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

12 December 2020

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

12 December 2020

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

1 reference

12 December 2020

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

1 reference

12 December 2020

The Peculiar Difficulties of Therapeutic Trials for Multiple Sclerosis

1 reference

12 December 2020

Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations

1 reference

12 December 2020

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

1 reference

12 December 2020

Acting on the cytokine balance to control auto-immunity and chronic inflammation.

1 reference

12 December 2020

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

1 reference

12 December 2020

10.2165/00002018-199717020-00002

Identifiers

DOI

1 reference

PubMed ID

9285200

Dimensions Publication ID

4 October 2017

0 references

1 reference

PubMed ID

9285200